These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3171885)

  • 1. Salivary excretion of 5-fluorouracil. II. Fluctuation of saliva/plasma concentration ratio and salivary clearance during a constant rate intravenous infusion in beagle dogs.
    Hayashi Y; Watanabe J; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1988 Jun; 11(6):438-43. PubMed ID: 3171885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary excretion of 5-fluorouracil (5-FU). IV. Dependency of saliva/plasma concentration ratio and salivary clearance on plasma concentration of 5-FU during constant-rate intravenous infusion in rats.
    Hayashi Y; Watanabe J; Ozeki S
    J Pharmacobiodyn; 1989 Mar; 12(3):137-44. PubMed ID: 2760793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary excretion of 5-fluorouracil. I. Fluctuation of the saliva/plasma concentration ratio and salivary clearance in beagle dogs following bolus intravenous administration.
    Watanabe J; Hayashi Y; Iwamoto K; Ozeki S
    Chem Pharm Bull (Tokyo); 1985 Mar; 33(3):1187-94. PubMed ID: 4028299
    [No Abstract]   [Full Text] [Related]  

  • 4. Dependency of salivary excretion of mexiletine on the plasma concentration in rats.
    Nagasako S; Iwamoto K; Hayashibara M; Katagiri Y
    J Pharm Pharmacol; 1993 Feb; 45(2):154-6. PubMed ID: 8095536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein binding effects of salivary excretion of phenobarbital in dogs.
    Watanabe J; Nakase Y; Urasaki Y; Hayashi Y; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1981 Dec; 4(12):968-77. PubMed ID: 7341753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary excretion of urea in dogs.
    Watanabe J; Mizuno S; Masuda N; Hayashi Y; Iwamoto K; Hirate J; Ozeki S
    J Pharmacobiodyn; 1984 May; 7(5):294-303. PubMed ID: 6470927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary passage of 5-fluorouracil during continuous infusion.
    Milano G; Thyss A; Santini J; Frenay M; Francois E; Schneider M; Demard F
    Cancer Chemother Pharmacol; 1989; 24(3):197-9. PubMed ID: 2736710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid.
    Joulia JM; Pinguet F; Ychou M; Duffour J; Astre C; Bressolle F
    Eur J Cancer; 1999 Feb; 35(2):296-301. PubMed ID: 10448274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excretion of indomethacin into saliva following intravenous administration to dogs.
    Watanabe J; Urasaki Y; Nakase Y; Ueda H; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1981 May; 4(5):336-44. PubMed ID: 7288551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary excretion of 5-fluorouracil (5-FU). V. Effect of 5-FU concentration in perfusate on the salivary excretion of 5-FU in perfused rat mandibular gland.
    Hayashi Y; Watanabe J
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):2008-11. PubMed ID: 2268905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary excretion of mexiletine after bolus intravenous administration in rats.
    Nagasako S; Hayashibara M; Katagiri Y; Iwamoto K
    J Pharm Pharmacol; 1992 Jan; 44(1):55-7. PubMed ID: 1350630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-organ relation between salivary gland and kidney in lithium excretion. I. Effects of continuous stimulation of salivation on salivary, renal and systemic clearances of lithium in dog.
    Watanabe J; Higuchi J; Hayashi Y; Yuasa H; Ozeki S
    J Pharmacobiodyn; 1988 Dec; 11(12):801-7. PubMed ID: 3254978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary excretion of 5-fluorouracil (5-FU). III. Non-linear kinetics of salivary excretion of 5-FU following bolus intravenous administration in rats.
    Hayashi Y; Watanabe J; Ozeki S; Iwamoto K
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4547-53. PubMed ID: 3246024
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between pharmacokinetics of 5-FU in plasma and in saliva, and toxicity of 5-fluorouracil/folinic acid.
    Jansman FG; Coenen JL; De Graaf JC; Tobi H; Sleijfer DT; Brouwers JR
    Anticancer Res; 2002; 22(6B):3449-55. PubMed ID: 12552938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Ethynyluracil (776C85): protection from 5-fluorouracil-induced neurotoxicity in dogs.
    Davis ST; Joyner SS; Baccanari DP; Spector T
    Biochem Pharmacol; 1994 Jul; 48(2):233-6. PubMed ID: 8053919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-organ relation between salivary gland and kidney in lithium excretion. IV. Saturation of inhibitory effect of NaCl on ductal reabsorption of Li+ in beagle dogs.
    Higuchi J; Watanabe J; Hayashi Y; Yuasa H
    Biol Pharm Bull; 1994 Feb; 17(2):356-8. PubMed ID: 8205139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-organ relation between salivary gland and kidney in lithium excretion. III. Enhanced salivary and systemic clearance of Li+ by oral administration of NaCl in dogs.
    Watanabe J; Higuchi J; Hayashi Y; Yuasa H; Ozeki S
    Chem Pharm Bull (Tokyo); 1990 Dec; 38(12):3428-33. PubMed ID: 2092941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-organ relation between salivary gland and kidney in lithium excretion. II. Salivary, renal and systemic clearances of lithium under continuous stimulation of salivation in water loaded dogs.
    Watanabe J; Higuchi J; Hayashi Y; Yuasa H; Ozeki S
    J Pharmacobiodyn; 1989 Sep; 12(9):537-43. PubMed ID: 2559185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mandibular and parotid salivary excretion of procainamide and N-acetylprocainamide after intravenous administration of procainamide to rats.
    Watanabe J; Koyama I; Iwamoto K; Ozeki S
    J Pharm Pharmacol; 1987 Nov; 39(11):912-6. PubMed ID: 2448449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.